For example, Eli Lilly's oral GLP-1 obesity treatment candidate, orforglipron, binds to the same site on the GLP-1 receptor but achieves high efficiency by binding through different amino acid residues (what remains after amino acids form a chain)
Stanford is funded by the National Institutes of Health NIDDK U24 DK132733, UE5 DK137285, and P30 DK040561
Highlights of 2024: The year the obesity market took shape The market for anti-obesity medications (AOMs) reached a major milestone in 2024 with global spend exceeding $30Bn for the first time, an over ten-fold increase since 2020
For researchers serious about optimizing their protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, proven protocols, and a community of thousands who have navigated these exact questions
Body mass index is a screening tool that uses height and weight to estimate body fat